4,7-二(5-溴-4-已基噻吩-2-基)苯并[c][1,2,5]硒二唑, 4,7-Bis(5-bromo-4-hexylthiophen-2-yl)benzo[c][1,2,5]selenadiazole

3-(5-溴噻吩基)-2,5-双(2-丁基辛基)-6-(噻吩基)吡咯并[3,4-C]吡咯-1,4(2H,5H)-二酮, 3-(5-Bromothiophen-2-yl)-2,5-bis(2-butyloctyl)-6-(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5h)-dione

2,4,6-三(3-(吡啶基)苯基)-1,3,5-三嗪, 2,4,6-Tris(3-(pyridin-3-yl)phenyl)-1,3,5-triazine

3-辛基噻吩并[3,2-b]噻吩, 3-Octyl-thieno[3,2-b]thiophene

2-(3',5'-二氟-[1,1'-联苯]-4-基)-4,4,5,5-四甲基-1,3,2-二氧杂硼戊烷, 2-(3',5'-Difluoro-[1,1'-biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

聚(DL-乳酸-co-乙醇酸), Poly(DL-lactide-co-glycolide), lactide:glycolide(85:15), end group: hydroxyl, average M.W. 69000-87000

聚(DL-乳酸-co-乙醇酸), Poly(DL-lactide-co-glycolide), lactide:glycolide(85:15), end group: carboxyl, average M.W. ≤5000

5-硝基嘧啶-4,6-二胺, 5-Nitrosopyrimidine-4,6-diamine

2-脱氧腺苷, 2-Deoxyadenosine

绞股蓝皂苷 LXXV, Gypenoside LXXV